ALPHARETTA, Ga., October 26, 2021 / PRNewswire-PRWeb / – Clint winters and Winters Biotechnology announced the filing of patents for their proprietary DualPolar â¢ active ingredient extraction process.
The DualPolar â¢ innovation marks a significant advance in the creation of new and effective dietary ingredients.
Traditionally, raw ingredient extractions are done with a “single solvent” extraction, which means that the production lab uses a single solvent in the entire process.
In the past, this was traditionally ethyl alcohol or hot water.
Over the past year, Winters Biotechnology has secretly tested and perfected a new approach to dual-solvent extraction.
This process is now called DualPolar â¢ extraction.
To date, this process is now fully patent protected, with a total of three individual patents protecting the entire process.
Medical scientist Clint winters had this to say about the deposit …
“After rigorous testing, the DualPolar â¢ Extraction System has shown much better efficiency when it comes to performing ‘full spectrum’ nutrient extraction, especially when it comes to an ingredient. raw with many active ingredients and varying polarities. “
DualPolar â¢ extraction has been found to be particularly useful when developing variants of natural conolidin, a flagship ingredient of Winters Biotechnology.
Mr Winters went on to say:
âAs we continue to innovate with our line of natural conolidine ingredients, our DualPolar â¢ innovation has become a critical technology. The raw ingredient, Tabernaemontana divaricata, contains 66 alkaloids of varying polarities. true full spectrum alkaloid extraction. “
When the active ingredients are extracted from a raw material, such as a plant, the solvent acts as a magnet separating the active compounds from the plant and suspending them in liquid form for possible consumption or absorption.
This magnetic separation effect is called “polarity”.
At first, Winters Biotechnology only used single solvent extraction methods, which was the industry standard but was not 100% efficient.
This problem is at the root of efforts to develop a DualPolar â¢ or dual solvent extraction method.
The goal was to achieve 100% full spectrum extraction regardless of the host raw material.
This method is able to efficiently extract all the active ingredients inside a compound, making it much more efficient than a single solvent extraction.
This had led to inventions of much more potent ingredients.
During the last year of testing, other key benefits were also discovered.
First, the DualPolar â¢ method naturally adds terpenes to the final extraction liquid.
Recently, terpenes (made famous by CBD) have been widely studied for their many medicinal benefits.
They are a significant advance in everything from pain relief to anti-aging.
Second, the DualPolar â¢ method has created a highly absorbable liquid that can be rapidly absorbed sublingually or transdermally.
In fact, this process is now crucial in two other innovations from Winters Biotechnology – the SubNano â¢ and TransNano â¢ nutrient delivery systems.
Research shows that the DualPolar â¢ extraction method assists in crossing the blood-brain barrier, a significant barrier for many natural nutrients.
Finally, it should be noted that the DualPolar â¢ extraction method can be used to extract thousands of raw materials producing a powerful extraction of active ingredient.
Many believe that the DualPolar â¢ method is the future of natural extraction science and will lead to the most potent natural food ingredients in history.
You can learn more about Winters Biotechnology and the DualPolar â¢ Extraction System by visiting WintersBiotechnology.com.
Winters Biotechnology is a medical innovation company based in Alpharetta, Georgia. The company is wholly owned by private equity firm Winters Capital Investments and was founded by a medical scientist, entrepreneur, entertainment figure and investor. Clint winters. The company is explicitly focused on creating unique dietary ingredients and innovative nutraceutical and pharmaceutical manufacturing methods that can be licensed by manufacturers.
In addition to the DualPolar â¢ patent filing, Mr. Winters also filed two patents with the natural pain reliever conolidine and an additional patent relating to the enhancement of CBD.
The company is currently developing two new drug delivery mechanisms that will be patented by the end of the year.
Earlier in his career, Mr. Winters developed and patented non-thermal infrared technology which is now used to accelerate healing and pain relief.
Spencer Jargon, Winters Biotechnology, 1-877-678-9719, email@example.com
SOURCE Winters Biotechnology